These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 23525395)
1. Quantitative assessment of tumor blood flow changes in a murine breast cancer model after adriamycin chemotherapy using contrast-enhanced destruction-replenishment sonography. Wang JW; Zheng W; Chen Y; Cao LH; Luo RZ; Li AH; Zhou JH J Ultrasound Med; 2013 Apr; 32(4):683-90. PubMed ID: 23525395 [TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced US quantitatively detects changes of tumor perfusion in a murine breast cancer model during adriamycin chemotherapy. Wang JW; Cao LH; Han F; Zheng W; Chen Y; Li AH; Zhou JH Acta Radiol; 2013 Oct; 54(8):882-8. PubMed ID: 23761553 [TBL] [Abstract][Full Text] [Related]
3. Assessment of early tumor response to cytotoxic chemotherapy with dynamic contrast-enhanced ultrasound in human breast cancer xenografts. Wang JW; Zheng W; Liu JB; Chen Y; Cao LH; Luo RZ; Li AH; Zhou JH PLoS One; 2013; 8(3):e58274. PubMed ID: 23469274 [TBL] [Abstract][Full Text] [Related]
4. Contrast-assisted destruction-replenishment ultrasound for the assessment of tumor microvasculature in a rat model. Pollard RE; Sadlowski AR; Bloch SH; Murray L; Wisner ER; Griffey S; Ferrara KW Technol Cancer Res Treat; 2002 Dec; 1(6):459-70. PubMed ID: 12625773 [TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of tumor blood flow in mice after treatment with different doses of an antiangiogenic agent with contrast-enhanced destruction-replenishment US. Zhou JH; Cao LH; Liu JB; Zheng W; Liu M; Luo RZ; Han F; Li AH Radiology; 2011 May; 259(2):406-13. PubMed ID: 21292869 [TBL] [Abstract][Full Text] [Related]
6. Ultrasonic spectrum analysis for in vivo characterization of tumor microstructural changes in the evaluation of tumor response to chemotherapy using diagnostic ultrasound. Lin CY; Cao LH; Wang JW; Zheng W; Chen Y; Feng ZZ; Li AH; Zhou JH BMC Cancer; 2013 Jun; 13():302. PubMed ID: 23800247 [TBL] [Abstract][Full Text] [Related]
7. Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. Niermann KJ; Fleischer AC; Huamani J; Yankeelov TE; Kim DW; Wilson WD; Hallahan DE J Ultrasound Med; 2007 Jun; 26(6):749-56. PubMed ID: 17526606 [TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin. Qi X; Chang Z; Song J; Gao G; Shen Z Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162 [TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice. Peterson CM; Lu JM; Sun Y; Peterson CA; Shiah JG; Straight RC; Kopecek J Cancer Res; 1996 Sep; 56(17):3980-5. PubMed ID: 8752167 [TBL] [Abstract][Full Text] [Related]
10. A method for assessing the microvasculature in a murine tumor model using contrast-enhanced ultrasonography. Loveless ME; Li X; Huamani J; Lyshchik A; Dawant B; Hallahan D; Gore JC; Yankeelov TE J Ultrasound Med; 2008 Dec; 27(12):1699-709. PubMed ID: 19022995 [TBL] [Abstract][Full Text] [Related]
11. [Prospective analysis of quantification of contrast media enhanced power Doppler sonography of equivocal breast lesions]. Pudszuhn A; Marx Ch; Malich A; Fleck M; Schneider A; Kaiser WA Rofo; 2003 Apr; 175(4):495-501. PubMed ID: 12677504 [TBL] [Abstract][Full Text] [Related]
13. Dose-response relationship in cisplatin-treated breast cancer xenografts monitored with dynamic contrast-enhanced ultrasound. Chen Y; Han F; Cao LH; Li C; Wang JW; Li Q; Zheng W; Guo ZX; Li AH; Zhou JH BMC Cancer; 2015 Mar; 15():136. PubMed ID: 25884471 [TBL] [Abstract][Full Text] [Related]
15. Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer. Wang H; Lutz AM; Hristov D; Tian L; Willmann JK Radiology; 2017 Feb; 282(2):443-452. PubMed ID: 27490690 [TBL] [Abstract][Full Text] [Related]
16. Corrected quantification method to determine myocardial blood flow using real-time myocardial contrast echocardiography. Otani K; Masuda K; Asanuma T; Ishikura F; Beppu S J Am Soc Echocardiogr; 2006 Aug; 19(8):973-81. PubMed ID: 16880091 [TBL] [Abstract][Full Text] [Related]
17. Early differentiating between the chemotherapy responders and nonresponders: preliminary results with ultrasonic spectrum analysis of the RF time series in preclinical breast cancer models. Li F; Huang Y; Wang J; Lin C; Li Q; Zheng X; Wang Y; Cao L; Zhou J Cancer Imaging; 2019 Aug; 19(1):61. PubMed ID: 31462322 [TBL] [Abstract][Full Text] [Related]
18. Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases. Merz M; Komljenovic D; Semmler W; Bäuerle T Invest Radiol; 2012 Jul; 47(7):422-9. PubMed ID: 22659593 [TBL] [Abstract][Full Text] [Related]
19. Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model. Wang H; Hristov D; Qin J; Tian L; Willmann JK Radiology; 2015 Nov; 277(2):424-34. PubMed ID: 26020439 [TBL] [Abstract][Full Text] [Related]
20. Sonographic evaluation of early-stage breast cancers that undergo neoadjuvant chemotherapy. Roubidoux MA; LeCarpentier GL; Fowlkes JB; Bartz B; Pai D; Gordon SP; Schott AF; Johnson TD; Carson PL J Ultrasound Med; 2005 Jul; 24(7):885-95. PubMed ID: 15972702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]